Methyl 4-Amino-2-Methoxybenzoate CAS 27492-84-8 Mama >98.0% (GC) Lenvatinib Mesylate Intermediate Factory

Fa'amatalaga Puupuu:

Igoa Vailaau: Methyl 4-Amino-2-Methoxybenzoate

CAS: 27492-84-8

Mama: >98.0% (GC)

Fa'aaliga: Pa'epa'e ile Pa'epa'e Pa'epa'e po'o tioata

Intermediate o Lenvatinib Mesylate CAS 857890-39-2

E-Mail: alvin@ruifuchem.com


Fa'amatalaga Oloa

Oloa Fa'atatau

Faailoga o oloa

Fa'amatalaga:

Meatotino tau vailaau:

Igoa Vailaau Methyl 4-Amino-2-Methoxybenzoate
Synonyms 4-Amino-2-Methoxybenzoic Acid Methyl Ester;Methyl 4-Amino-o-Anisate;4-Amino-o-Anisic Acid Methyl Ester
Numera CAS 27492-84-8
CAT Numera RF-PI1974
Tulaga Fa'asoa I Fa'atauga, Oloa Fua e O'o i Tone
Fuafua mole C9H11NO3
Molecular Weight 181.19
Malosi 1.179±0.060g/cm3
Fa'ailoga Ruifu Chemical

Fa'amatalaga:

Aitema Fa'amatalaga
Fa'aaliga Pa'epa'e i le Pa'epa'e Pa'epa'e po'o tioata
Mama / Suʻesuʻega Metotia >98.0% (GC)
Mama / Suʻesuʻega Metotia 97.5~102.5 (Titration e le o ninaqueous)
Lisi Lisi 157.0~161.0 ℃
Ma'imau ile Fa'amago <1.00%
Aofa'i Fa'aleaga <2.0%
Alaleo Infrared E tusa ai ma le Fauga
Proton NMR Alaleo E tusa ai ma le Fauga
Tulaga Su'ega Pisinisi Tulaga
Fa'aoga Intermediate o Lenvatinib Mesylate (CAS: 857890-39-2)

Paket & Teuina:

afifi: Fagu, ato pepa alumini, 25kg/Kati Pusa, pe tusa ai ma manaoga o tagata faatau

Tulaga teuina:Teu i totonu o pusa faʻamaufaʻailoga i se nofoaga malulu ma mago;Puipui mai le malamalama ma le susu

Tulaga lelei:

1

FAQ:

Talosaga:

Methyl 4-Amino-2-Methoxybenzoate (CAS: 27492-84-8) e mafai ona faʻaaogaina e fai ma sui o le Lenvatinib Mesylate (CAS: 857890-39-2).Lenvatinib o se vailaʻau o le kanesa o le thyroid na atiaʻe e le Eisai Corporation o Iapani (Code: E7080), o loʻo iai i le inhibitor of oral multi-receptor tyrosine kinase (RTK) ma e mafai ona faʻalavelaveina le gaioiga kinase o le vascular endothelial growth factor (VEGF) Receptors VEGFR1 ( FLT1), VEGFR2 (KDR), ma VEGFR3 (FLT4).Lenvatinib e mafai foi ona taofia le aʻafia o isi RTK i pathological angiogenesis, tuputupu aʻe o le tuma, ma le alualu i luma o le kanesa sei vagana ai a latou galuega masani feaveaʻi e aofia ai le fibroblast growth factor (FGF) receptors FGFR1, 2, 3, ma le 4;e maua mai le platelets growth factor receptor (PDGFR [alpha]), KIT, ma le RET.[Fa'ailoga]: Lenvatinib e talafeagai mo togafitiga o gasegase o thyroid kanesa o le toe fa'afo'i mai i le lotoifale po'o le metastasis ituaiga, tulaga alualu i luma ma le radioactive iodine-refractory differentiated type.I le aso 13 o Fepuari, 2015, na faʻamaonia ai e le US FDA le vailaʻau faʻamaʻi faʻamaʻi Lenvatinib mo togafitiga o le kanesa thyroid.Lenvatinib o se fa'atosina enzyme e tele-target, e mafai ona fa'alavelaveina le VEGFR2 ma le VEGFR3 (vascular endothelial growth factor receptor).Ole igoa tau fefa'ataua'iga ole Lenvatinib ole Lenvima.I le aso 20 o Me, 2015, na faʻamaonia ai e le European Medicines Agency (EMA) le Lenvatinib mo le togafitia o faʻamaʻi pipisi, faʻa-lotoifale poʻo metastatic differentiated (papillary, follicular, Hurthle type) thyroid cancer (DTC).I le faamasinoga, o le umi o le ola mo tagata mamaʻi o le radioactive iodine-refractory DTC na togafitia ma Lenvatinib e 18 masina ae o le tau mo tagata mamaʻi e ave placebo e naʻo le 3 masina.

Tusi lau savali iinei ma lafo mai ia i matou